Clinical Trial Update: Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens for the Treatment of Potentially Hazardous Colorectal Cancer SD Status [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating nocardia rubra cell wall skeleton in combination with prior second- or third-line regimens for potentially hazardous colo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Neoplasms

Drugs mentioned

• Nocardia rubra cell wall skeleton (Nocardia rubra cell wall skeleton)

Snippet

Sponsor: Sun Jing | Conditions: Colorectal Cancer, Colorectal Neoplasms | Phase 2 | Status: RECRUITING